Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131426 · ClinicalTrials.gov registry record · Phase 1
Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT04131426 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 25 participants.
The verdict
NCT04131426, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The main purpose of this research study is to determine if the use of a nutritional supplement and exercise improve or worsen cachexia.
Interventions
- OTHER EXCAP©®
- DRUG Remune
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-04-24 |
| Est. Completion | 2022-04-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04131426
The ClinicalTrials.gov registry entry for NCT04131426 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EXCAP©® is the first listed.
NCT04131426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04131426 about?
NCT04131426 is a clinical study titled "Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia". The main purpose of this research study is to determine if the use of a nutritional supplement and exercise improve or worsen cachexia.
What is the current status of trial NCT04131426?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2020-04-24. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT04131426?
The interventions under investigation include: EXCAP©® (OTHER), Remune (DRUG).
Who is sponsoring clinical trial NCT04131426?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.